Expert Rev Clin Pharmacol. 2010;3(3):321-329. Torsades de pointes (TdP) arrhythmia is a potentially life-threatening cardiac disorder that is often associated with a prolonged QT interval in the ...
The Global HERG Screening Market is projected to experience substantial growth over the next decade. The market size, valued at USD 1,938.0 million in 2023, is expected to reach approximately USD ...
MHRA has made the company a member of the UK GLP compliance monitoring programme MHRA has made the company a member of the UK GLP compliance monitoring programme Metrion Biosciences, a company focused ...
New York, NY, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Polaris Market Research has published a recent study report titled "HERG Screening Market Share, Size, Trends, Industry Analysis Report, By Product Type ...
Repolarization abbreviation with the antiarrhythmic drug mexiletine has been found to normalize the QTc interval and reduce the rate of events in long QT syndrome type 3 (LQT3), but it is only ...
Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced it has received notification from the UK’s Medicines and Healthcare ...
Expert Rev Clin Pharmacol. 2010;3(3):321-329. Despite a propensity to block hERG channel function, as determined by electrophysiology, for a limited number of compounds no cardiac arrhythmias have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results